Total Payments
$1,412
2024 Payments
$145.70
Companies
12
Transactions
30
Medicare Patients
9,579
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$1,384 (98.0%)
Education$27.78 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,384 | 28 | 98.0% |
| Education | $27.78 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $269.11 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $197.77 | 2 | $0 (2018) |
| La Jolla Pharmaceutical Company | $186.81 | 1 | $0 (2023) |
| PORTOLA PHARMACEUTICALS, INC. | $180.70 | 2 | $0 (2019) |
| NuVasive, Inc. | $150.00 | 1 | $0 (2021) |
| Stryker Corporation | $139.91 | 1 | $0 (2019) |
| Electromed, Inc. | $128.97 | 12 | $0 (2021) |
| GlaxoSmithKline, LLC. | $59.22 | 3 | $0 (2019) |
| Resmed Corp | $39.87 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.78 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.70 | 2 | AstraZeneca Pharmaceuticals LP ($145.70) |
| 2023 | $326.87 | 3 | La Jolla Pharmaceutical Company ($186.81) |
| 2021 | $176.73 | 3 | NuVasive, Inc. ($150.00) |
| 2019 | $342.04 | 4 | PORTOLA PHARMACEUTICALS, INC. ($180.70) |
| 2018 | $177.47 | 11 | Electromed, Inc. ($89.54) |
| 2017 | $243.13 | 7 | Janssen Pharmaceuticals, Inc ($124.99) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $114.74 | General |
| Category: Rare Disease | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: Rare Disease | ||||||
| 08/24/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $186.81 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $123.41 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 04/03/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2021 | NuVasive, Inc. | ALIF (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Spine/Spine Surgery | ||||||
| 08/10/2021 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.17 | General |
| Category: HFCWO | ||||||
| 04/14/2021 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.56 | General |
| Category: HFCWO | ||||||
| 11/11/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $38.55 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 05/07/2019 | Stryker Corporation | TREVO (Device) | Food and Beverage | Cash or cash equivalent | $139.91 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 01/23/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $142.15 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 12/13/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.02 | General |
| Category: HFCWO | ||||||
| 11/30/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: HFCWO | ||||||
| 09/13/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: HFCWO | ||||||
| 08/08/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $72.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $10.73 | General |
| Category: HFCWO | ||||||
| 06/15/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.35 | General |
| Category: HFCWO | ||||||
| 04/23/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.59 | General |
| Category: HFCWO | ||||||
| 04/23/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $2.41 | General |
| Category: HFCWO | ||||||
| 04/23/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.19 | General |
| Category: HFCWO | ||||||
| 01/29/2018 | Gilead Sciences, Inc. | Letairis (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: PAH | ||||||
| 01/18/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.30 | General |
| Category: HFCWO | ||||||
| 12/15/2017 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $12.70 | General |
| Category: HFCWO | ||||||
| 12/12/2017 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,471 | 3,495 | $2.0M | $492,200 |
| 2022 | 21 | 2,624 | 3,669 | $2.0M | $503,486 |
| 2021 | 21 | 2,227 | 3,260 | $1.8M | $517,374 |
| 2020 | 21 | 2,257 | 3,796 | $1.9M | $570,874 |
Total Patients
9,579
Total Services
14,220
Medicare Billing
$2.1M
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 736 | 1,371 | $630,660 | $158,052 | 25.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 114 | 115 | $281,750 | $79,742 | 28.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 107 | 108 | $245,700 | $71,579 | 29.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 145 | 335 | $345,046 | $64,437 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 345 | 394 | $128,050 | $32,741 | 25.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 96 | 169 | $58,281 | $18,539 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 69 | $43,815 | $11,029 | 25.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 85 | 99 | $45,540 | $10,792 | 23.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 168 | 177 | $23,187 | $9,960 | 43.0% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 90 | 92 | $55,200 | $8,575 | 15.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 166 | 174 | $17,748 | $7,101 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $25,660 | $6,340 | 24.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 165 | 172 | $41,280 | $6,031 | 14.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 93 | 99 | $11,880 | $3,130 | 26.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 40 | $9,708 | $2,918 | 30.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 18 | $2,356 | $812.88 | 34.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 17 | $1,445 | $418.88 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 606 | 1,208 | $555,680 | $136,670 | 24.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 131 | 137 | $335,650 | $93,304 | 27.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 149 | 358 | $347,260 | $69,603 | 20.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 94 | 97 | $220,675 | $62,401 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 308 | 359 | $116,675 | $27,412 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 149 | 149 | $87,165 | $20,923 | 24.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 105 | 194 | $66,348 | $18,106 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 78 | 108 | $68,580 | $17,264 | 25.2% |
About Dr. Harish Murthy, MD
Dr. Harish Murthy, MD is a Sleep Medicine healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922074061.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harish Murthy, MD has received a total of $1,412 in payments from pharmaceutical and medical device companies, with $145.70 received in 2024. These payments were reported across 30 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,384).
As a Medicare-enrolled provider, Murthy has provided services to 9,579 Medicare beneficiaries, totaling 14,220 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Neurocritical Care, Internal Medicine
- Location San Jose, CA
- Active Since 02/28/2006
- Last Updated 03/03/2025
- Taxonomy Code 207RS0012X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922074061
Products in Payments
- ANDEXXA (Biological) $326.40
- XARELTO (Drug) $197.77
- GIAPREZA (Drug) $186.81
- ALIF (Device) $150.00
- TREVO (Device) $139.91
- SMARTVEST (Device) $128.97
- SAPHNELO (Biological) $123.41
- AirFit (Device) $39.87
- TRELEGY ELLIPTA (Drug) $37.15
- STIOLTO (Drug) $27.78
- ANORO (Drug) $22.07
- INSPIRE (Device) $16.65
- Letairis (Drug) $15.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.